J&J Unit Loses Out To Medtronic In Stent Case
In a big upset for Johnson & Johnson, an arbitration panel has ruled that a Medtronic Inc. coronary stent does not infringe on its rival's patents, giving Medtronic the opportunity to...To view the full article, register now.
Already a subscriber? Click here to view full article